The EU is highly conservative when it comes to drug approvals and has a protectionist system that favours big European incumbents and stifles innovation. This is why the US has been leading in health tech for so long. Hopefully our exit from the EU will change that.
The UK’s small businesses could blossom in a post-Brexit Britain, with a number of sectors perhaps benefiting from our EU exit